May 1, 2007
Gluskin ends trading Wednesday
By Matthew L. Brown
Anna Gluskin, chairman and CEO of Worcester-based Generex Biotechnology Corp., is scheduled to ring the closing bell at the NASDAQ stock market Wednesday.
Gluskin will be at 4 Times Square to ring the ceremonial bell at 4 p.m. The bell-ringing can be watched on the NASDAQ website.
Generex develops drug-delivery methods for the treatment of metabolic diseases. The company's products are delivered through the inner lining of the mouth.
Gluskin said the company's oral insulin spray is of particular interest.
Gluskin will be at 4 Times Square to ring the ceremonial bell at 4 p.m. The bell-ringing can be watched on the NASDAQ website.
Generex develops drug-delivery methods for the treatment of metabolic diseases. The company's products are delivered through the inner lining of the mouth.
Gluskin said the company's oral insulin spray is of particular interest.
WBJ Web Partners
Most Recent
Most Recent
0 Comments